GE HealthCare Technologies GEHC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Profitability | ||||
| Gross margin | 164.4%-0.4pp | 164.7%+5.2pp | 159.5%+0.5pp | |
| Operating margin | 54.4%+3.3pp | 51.2%-1.3pp | 52.5%-4.3pp | |
| Net margin | 43.3%+8.5pp | 34.8%-1.9pp | 36.7%-7.7pp | |
| Returns | ||||
| Return on equity | 98.3%+7.5pp | 90.7%— | —— | |
| Return on invested capital | 47%+5.5pp | 41.5%— | —— | |
| Efficiency | ||||
| Asset turnover | 2.4×0.0× | 2.4×— | —— | |
| Liquidity | ||||
| Current ratio | 4.7×+0.3× | 4.4×-0.3× | 4.7×— | |
| Leverage | ||||
| Debt-to-equity | 4.2×-0.8× | 4.9×-1.0× | 5.9×— | |
| Net debt / EBITDA | 12.4×-0.4× | 12.8×-0.5× | 13.3×— | |
| Per Share | ||||
| Book value per share | $85.75+23.1% | $69.66+13.7% | $61.29— | |
| Valuation | ||||
| Market capitalization | $141.52B-9.0% | $155.59B+10.8% | $140.43B— | |
| Price / earnings | 65×-27.4× | 92.4×+12.1× | 80.3×— | |
| Price / sales | 7×-0.9× | 8×+0.6× | 7.3×— | |
| Price / book | 14.4×-5.1× | 19.5×-0.5× | 20.1×— | |
| EV / EBITDA | 55.1×-8.0× | 63.1×+5.0× | 58.1×— | |
| Dividend yield | 0.7%+0.1pp | 0.6%— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GE HealthCare Technologies's profit margins?
- GE HealthCare Technologies (GEHC) runs a 39.1% gross margin and a 12.6% operating margin, with a 9.1% net margin.
- Where do GE HealthCare Technologies's ratios come from?
- Every ratio is computed from GE HealthCare Technologies's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
